MetaCap

InfuSystems (INFU) vs Orthofix Medical (OFIX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

InfuSystems (INFU) has outperformed Orthofix Medical (OFIX) over the past year, gaining 51.7% versus a loss of 60.2%. Over five years, INFU leads with a -15.9% price change compared with -80.6% for OFIX. InfuSystems is the larger company by market cap ($287.5 million vs $247.4 million), about 1.2 times the size.

On valuation, InfuSystems trades at a lower forward P/E (25.6x vs 33.7x for Orthofix Medical). InfuSystems converts more of its revenue into profit, with a net margin of 4.6% versus -11.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INFU+51.69%OFIX-60.22%
+68%+1%-66%
Nov 21, 20251 yearNov 20, 2026
INFU-19.70%OFIX-80.46%
+20%-33%-85%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INFU versus OFIX key metrics
MetricINFUOFIX
Share price$14.35$6.07
Market cap$287.48M$247.41M
1-day change+2.06%-4.26%
YTD return+59.98%-59.96%
1-year return+51.69%-60.22%
5-year return-15.93%-80.64%
P/E ratio (TTM)32.61—
Forward P/E25.6333.72
EPS (TTM)$0.44$-1.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$143.44M$822.31M
Revenue growth (YoY)+6.36%+2.85%
Net income (latest FY)$6.63M$-92.19M
Gross margin55.98%68.83%
Operating margin8.31%-9.90%
Net margin4.62%-11.21%
52-week high$15.47$16.42
52-week low$7.29$6.04
Distance from 52-week high-7.24%-63.03%
Analyst consensusstrong_buybuy
Avg. price target upside+28.92%+64.74%
Average volume136.60K481.16K
Shares outstanding20.03M40.76M
Employees4611,605
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • INFU has outperformed OFIX by 111.9 percentage points over the past year.
  • InfuSystems is more profitable, keeping 4.6 cents of every revenue dollar as net income versus -11.2 cents for Orthofix Medical.

About InfuSystems

INFU stock →

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.

Health Care · Medical/Dental Instruments · 461 employees

About Orthofix Medical

OFIX stock →

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.

Health Care · Medical/Dental Instruments · 1,605 employees

INFU vs OFIX FAQ

Which is bigger, InfuSystems or Orthofix Medical?

InfuSystems (INFU) is larger, with a market capitalization of $287.48M compared with $247.41M for Orthofix Medical (OFIX).

Which stock has performed better over the past year, INFU or OFIX?

INFU returned +51.69% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.

Are InfuSystems and Orthofix Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons